Lyophilisate for liquid infusions solution 150 mg
International unlicensed name:
Antibiotic — rifampicine
Tuberculosis (all forms) — as part of a combined therapy.
Cutaneous leprosy (in combination with dapsone — multibinomial type of disease).
Infection diseases caused by microorganisms, sensitive to rifampicin (in resistance cases to other antibiotics and as part of combined antimicrobical therapies; after an exception of the diagnosis of tuberculosis and a leprosy). The Brucellosis — as part of combined therapy with antibiotics of tetracycline group (doxycycline). Meningococcal meningitis (prevention at the persons which are in close contact with the diseased cerebrospinal fever; bacillicarriers Neisseria meningitidis).
Hypersensibility to medicine components, jaundice, recently postponed (less than 1 year) infectious hepatitis, a chronic renal failure, heavy pulmonary heart failure, nurseries age till 1 year.
150 mg of rifampicin in the ampoules made of light-protective neutral glass has capacity of 5 ml of the NS-1 or NS-3 brand. Ampoules placed in planimetric plastic package (pallet) made of polyvinylchloride film or polietilentereftalatnoa film.
20, 25, 50, 100, 200 planimetric plastic packages (pallets) or planimetric cell packages and apllications instructions in the box made of cardboard.